{
    "2018-07-10": [
        [
            {
                "time": "",
                "original_text": "[看好评级]医药生物行业2018年中报业绩前瞻：医疗需求刚性 重点关注稳健成长和“流量入口”型公司",
                "features": {
                    "keywords": [
                        "医药生物",
                        "中报业绩",
                        "医疗需求",
                        "稳健成长",
                        "流量入口"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "[推荐评级]医药生物行业2018年中报业绩前瞻：重点覆盖公司中报业绩前瞻：关注2季度增速加快个股",
                "features": {
                    "keywords": [
                        "医药生物",
                        "中报业绩",
                        "2季度",
                        "增速加快",
                        "个股"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}